Saturday 17 October 2026
Export MD’s income statement to Excel — free account
Pediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024. In the quarter to June 2026, revenue grew 4.04%, EPS grew 6.52%, free cash flow fell 6.56% and total debt fell 3.84%, each against the same quarter a year earlier.
27.38
0.38
−1.37%
Follow MD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
11.03 | 0.00 | 0.00 | 18.78 | 17.78 | 0.00 | 0.00 | 11.26 | 15.87 | 19.13 |
Piotroski F-Score |
7 | 5 | 5 | 6 | 6 | 6 | 5 | 6 | 4 | 5 |
Altman Z-Score |
2.05 | 1.26 | 1.20 | 1.54 | 1.81 | 1.36 | 1.32 | 1.59 | 2.38 | 2.88 |
P/S ratio |
0.94 | 0.54 | 0.39 | 0.64 | 1.21 | 1.20 | 1.00 | 1.74 | 1.56 | 1.94 |
P/FCF ratio |
7.12 | 5.92 | 7.41 | 9.14 | 33.35 | 11.87 | 6.84 | 10.14 | 10.43 | 15.30 |
Altman Z″-Score (non-manufacturers) |
2.05 | 0.61 | 0.73 | 1.02 | 1.83 | 2.39 | 1.57 | 2.74 | 2.92 | 3.10 |
Beneish M-Score |
(2.86) | (3.29) | (2.90) | (2.53) | (2.00) | (3.37) | (3.10) | (2.20) | (2.54) | (2.51) |
P/Operating CF |
15.76 | 8.22 | 11.13 | 12.70 | 52.18 | (175.96) | 17.11 | 19.86 | 25.86 | 47.27 |
P/B ratio |
2.08 | 1.43 | 0.91 | 1.41 | 2.57 | 2.79 | 1.54 | 0.97 | 1.65 | 2.24 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.99 | 0.68 | 0.62 | 0.91 | 1.48 | 1.50 | 1.67 | 2.85 | 2.10 | 2.46 |
EV/EBITDA |
8.19 | 0.00 | 27.42 | 8.58 | 11.80 | 19.47 | 15.05 | 17.72 | 12.69 | 11.76 |
EV/Operating CF |
6.99 | 6.60 | 8.93 | 10.79 | 36.83 | 12.73 | 10.86 | 15.66 | 13.38 | 17.64 |
EV/FCF |
7.51 | 7.38 | 11.79 | 13.13 | 40.83 | 14.81 | 11.48 | 16.57 | 14.10 | 19.35 |
Quick Ratio |
1.62 | 1.43 | 1.18 | 0.94 | 1.88 | 3.31 | 1.14 | 1.14 | 1.08 | 1.25 |
Current Ratio |
1.66 | 1.47 | 1.24 | 1.00 | 1.97 | 3.49 | 1.35 | 1.31 | 1.18 | 1.31 |
Net Debt/EBITDA |
0.42 | (7.57) | 10.19 | 2.61 | 2.16 | 3.86 | 7.70 | 6.88 | 3.31 | 2.46 |
Debt/Assets |
26.59% | 28.69% | 28.53% | 27.74% | 36.90% | 52.12% | 42.17% | 33.26% | 31.58% | 31.95% |
Debt/Equity |
0.69 | 0.81 | 0.75 | 0.73 | 1.12 | 2.33 | 1.17 | 0.64 | 0.60 | 0.62 |
Asset Turnover |
0.87 | 0.92 | 0.87 | 0.78 | 0.63 | 0.46 | 0.35 | 0.29 | 0.58 | 0.64 |
Operating CF/Net income |
1.64 | (2.09) | (2.27) | 2.52 | 0.59 | (0.26) | (0.24) | 1.17 | 1.60 | 1.37 |
Capex/Depreciation |
(0.81) | (0.66) | (0.89) | (0.79) | (0.21) | (0.81) | (0.61) | (0.59) | (0.31) | (0.42) |
Interest Coverage |
5.81 | (1.69) | 0.17 | 4.35 | 2.95 | 0.89 | 1.44 | 2.67 | 6.10 | 9.06 |
| 20.28% | (12.28%) | (6.94%) | 7.42% | 15.93% | (70.90%) | (65.30%) | 8.73% | 11.00% | 12.50% | |
| 7.52% | (4.53%) | (2.65%) | 2.62% | 4.31% | (21.26%) | (29.71%) | 4.55% | 5.72% | 6.57% | |
ROIC |
13.55% | (4.15%) | 0.35% | 7.50% | 8.97% | 4.85% | 3.50% | 3.11% | 5.86% | 8.12% |
Return on Tangible Assets |
48.11% | (40.49%) | (35.50%) | 89.28% | 27.09% | (67.43%) | (570.84%) | 108.47% | 146.06% | 134.68% |
Average Days of Receivables |
46.21 | 49.43 | 51.22 | 54.93 | 60.35 | 50.93 | 89.06 | 107.34 | 56.54 | 56.79 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
12.58% | 11.85% | 11.41% | 11.73% | 13.78% | 14.36% | 13.74% | 13.48% | 11.86% | 11.70% |
Intangible Assets out of Total Assets |
0.57 | 0.58 | 0.63 | 0.66 | 0.56 | 0.45 | 0.36 | 0.74 | 0.84 | 0.85 |
Share Based Compensation of Revenue |
0.94% | 0.59% | 0.62% | 0.82% | 0.99% | 2.25% | 1.88% | 2.12% | 0.88% | 1.07% |
Graham Net Nets |
(0.34) | (0.68) | (1.15) | (0.82) | (0.43) | (0.50) | (0.83) | (0.73) | (0.43) | (0.32) |
Graham Number |
21.20 | 0.00 | 0.00 | 13.87 | 19.08 | 0.00 | 0.00 | 47.27 | 50.75 | 48.50 |
Earnings Yield |
9.07% | (9.15%) | (7.78%) | 5.33% | 5.62% | (38.75%) | (64.92%) | 8.88% | 6.30% | 5.23% |
Free Cash Flow Yield |
14.05% | 16.88% | 13.49% | 10.95% | 3.00% | 8.42% | 14.62% | 9.87% | 9.59% | 6.54% |
Revenue per Share |
22.76 | 24.16 | 24.27 | 23.63 | 22.53 | 20.79 | 21.32 | 18.91 | 35.20 | 34.44 |
Operating CF per Share |
3.22 | 2.48 | 1.67 | 2.00 | 0.90 | 2.45 | 4.28 | 3.44 | 5.53 | 4.80 |
Capex per Share |
(0.22) | (0.26) | (0.41) | (0.36) | (0.09) | (0.35) | (0.23) | (0.19) | (0.28) | (0.42) |
Free Cash Flow per Share |
3.00 | 2.21 | 1.27 | 1.64 | 0.82 | 2.11 | 4.05 | 3.26 | 5.25 | 4.38 |
Cash per Share |
5.94 | 4.18 | 2.16 | 1.23 | 5.74 | 14.73 | 2.18 | 0.74 | 0.76 | 0.72 |
Shareholders Equity per Share |
10.30 | 9.18 | 10.33 | 10.68 | 10.57 | 8.97 | 17.95 | 33.89 | 33.18 | 29.87 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.30 | 9.18 | 10.33 | 10.68 | 10.57 | 8.97 | 17.95 | 33.89 | 33.18 | 29.87 |
Free Cash Flow |
252.63 | 184.55 | 104.00 | 137.23 | 69.22 | 175.83 | 338.44 | 296.59 | 485.23 | 404.51 |
Working Capital |
304.60 | 205.50 | 94.51 | 1.01 | 413.20 | 1,105.01 | 189.69 | 157.22 | 95.81 | 138.18 |
Capital Expenditures |
(18.46) | (22.02) | (33.33) | (29.71) | (7.52) | (28.79) | (19.27) | (17.12) | (26.15) | (39.26) |
Net Current Asset Value |
(617.33) | (748.15) | (887.29) | (1,028.27) | (985.29) | (1,050.88) | (1,915.40) | (2,189.62) | (2,173.59) | (1,991.50) |
EV/EBIT |
9.08 | 0.00 | 167.55 | 10.43 | 13.93 | 26.54 | 17.15 | 19.78 | 15.04 | 13.69 |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
8.61 | 0.00 | 105.32 | 7.26 | 11.38 | 21.28 | 10.22 | 12.10 | 11.12 | 10.83 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.58 | 0.85 | 0.49 | 0.51 | 0.52 | 0.47 | 0.43 | 0.32 | 0.68 | 0.91 |
Cash ROIC |
12.87% | 10.66% | 6.26% | 8.34% | 2.90% | 4.73% | 9.87% | 5.78% | 9.72% | 8.92% |
Accounts Receivable Turnover |
7.43 | 7.29 | 6.92 | 6.44 | 6.85 | 5.13 | 3.78 | 3.41 | 6.51 | 6.77 |
Accounts Payable Turnover |
3.47 | 4.16 | 4.34 | 3.92 | 3.42 | 3.08 | 2.97 | 2.75 | 5.52 | 5.35 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
107.83 | 93.37 | 81.40 | 90.76 | 102.90 | 120.24 | 117.40 | 134.41 | 68.51 | 69.27 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
257.46 | 276.24 | 288.33 | 306.41 | 278.98 | 338.10 | 470.49 | 505.36 | 499.64 | 470.01 |
Average Payables |
409.11 | 374.74 | 362.51 | 384.17 | 408.65 | 416.91 | 429.60 | 443.29 | 422.98 | 401.87 |
Average Assets |
2,199.70 | 2,186.26 | 2,283.85 | 2,535.22 | 3,035.25 | 3,746.92 | 5,041.69 | 5,902.38 | 5,603.34 | 4,943.31 |
Average Common Equity |
815.40 | 807.00 | 870.35 | 894.16 | 822.20 | 1,123.36 | 2,293.44 | 3,077.17 | 2,913.61 | 2,599.31 |
Columns are period end dates